XML 21 R24.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Segment and Geographic Information and Significant Customers
 3 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Segment and Geographic Information and Significant Customers
Our Chief Operating Decision Maker ("CODM") regularly reviews segment revenues and segment profits for performance evaluation and resources allocation. Segment revenues include certain acquisition-related adjustments for revenues that would otherwise have been recognized without the acquisition. Segment profits reflect controllable costs directly related to each segment and the allocation of certain corporate expenses such as, corporate sales and marketing expenses and research and development project costs that benefit multiple segments. Certain items such as stock-based compensation, amortization of intangible assets, acquisition-related costs, net, restructuring and other charges, net, other expenses, net and certain unallocated corporate expenses are excluded from segment profits, which allow for more meaningful comparisons to the financial results of the historical operations for performance evaluation and resources allocation by our CODM.
•
The Healthcare segment is primarily engaged in providing clinical speech and clinical language understanding solutions that improve the clinical documentation process, from capturing the complete patient record to improving clinical documentation and quality measures for reimbursement.
•
The Enterprise segment is primarily engaged in using speech, natural language understanding, and artificial intelligence to provide automated customer solutions and services for voice, mobile, web and messaging channels.
•
The Other segment includes voicemail transcription services, Mobile Operator Services, and our Devices business. In May 2019, we completed the sale of our Mobile Operator Services business in Brazil, and July 2019, we completed the sale of our Mobile Operator Services business in India.
As more fully described in Note 4, on October 1, 2019, we completed the spin-off of our Automotive business as an independent publicly traded company. Effective the first quarter of fiscal year 2020, our Automotive business's historical results of operations have been included within discontinued operations. For the three months ended December 31, 2018, $4.2 million of stranded costs previously allocated to our Automotive segment have been re-allocated to Healthcare, Enterprise, and Other.
We do not track our assets by segment. Consequently, it is not practical to show assets or depreciation by segment. The following table presents segment results along with a reconciliation of segment profit to Income before income taxes (dollars in thousands): 
 
Three Months Ended December 31,
 
2019
 
2018
Segment revenues:
 
 
 
Healthcare
$
270,534

 
$
271,978

Enterprise
138,473

 
129,692

Other
9,315

 
18,358

Total segment revenues
418,322

 
420,028

Less: acquisition-related revenues adjustments
(89
)
 
(353
)
Total revenues
418,233

 
419,675

Segment profit:
 
 
 
Healthcare
93,279

 
102,556

Enterprise
42,536

 
42,282

Other
5,128

 
5,335

Total segment profit
140,943

 
150,173

Corporate expenses and other, net
(30,489
)
 
(35,114
)
Acquisition-related revenues
(89
)
 
(353
)
Stock-based compensation
(31,233
)
 
(29,497
)
Amortization of intangible assets
(19,176
)
 
(21,198
)
Acquisition-related costs, net
(1,167
)
 
(2,601
)
Restructuring and other charges, net
(6,683
)
 
(14,641
)
Other expenses, net
(33,669
)
 
(30,888
)
Income before income taxes
$
18,437

 
$
15,881


No country outside of the United States provided greater than 10% of our total revenues. Revenues, classified by the major geographic areas in which our customers are located, were as follows (dollars in thousands): 
 
Three Months Ended December 31,
 
2019
 
2018
United States
$
346,810

 
$
345,977

International
71,423

 
73,698

Total revenues
$
418,233

 
$
419,675